Quantification of deficits in spatial visual function of mouse models for glaucoma

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3654-3659

  Burroughs, Stephanie L ^a   Kaja, Simon ^a   Koulen, Peter ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; CORNEA REFLEX; DBA 2 MOUSE; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; MOUSE; NONHUMAN; OPTOKINETIC RESPONSE; PRIORITY JOURNAL; TONOMETER; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; AGING; ANIMAL; DBA MOUSE; DEPTH PERCEPTION; DISEASE MODEL; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; OPTOKINETIC NYSTAGMUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; CONTRAST SENSITIVITY; DISEASE MODELS, ANIMAL; GLAUCOMA, OPEN-ANGLE; INTRAOCULAR PRESSURE; MALE; MICE; MICE, INBRED DBA; NYSTAGMUS, OPTOKINETIC; SPACE PERCEPTION; TONOMETRY, OCULAR; VISUAL ACUITY; VISUAL PERCEPTION;

EID: 80051741689     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7106     Document Type: Article

References (41)

1. Sena DF, Ramchand K, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2010;2: CD006539.
2. Chiu K, Yeung SC, So KF, Chang RC. Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol Immunol. 2010;7:61-68.
3. Bessero AC, Clarke PG. Neuroprotection for optic nerve disorders. Curr Opin Neurol. 2010;23:10-15.
4. Chidlow G, Wood JP, Casson RJ. Pharmacological neuroprotection for glaucoma. Drugs. 2007;67:725-759.
5. Calkins DJ, Horner PJ, Roberts R, Gradianu M, Berkowitz BA. Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Invest Ophthalmol Vis Sci. 2008;49:5083-5088.
6. Haefliger IO, von Arx G, Pimentel AR. Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review. Klin Monbl Augenheilkd. 2010;227:292-293.
7. Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res. 2010;91:48-53.
8. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
9. McKinnon SJ, Schlamp CL, Nickells RW. Mouse models of retinal ganglion cell death and glaucoma. Exp Eye Res. 2009;88:816-824.
10. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
11. Inman DM, Sappington RM, Horner PJ, Calkins DJ. Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:986-996.
12. Crish SD, Calkins DJ. Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience. 2011;176:1-11.
13. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107:5196-5201.
14. Baltan S, Inman DM, Danilov CA, Morrison RS, Calkins DJ, Horner PJ. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J Neurosci. 2010;30:5644-5652.
15. Douglas RM, Alam NM, Silver BD, McGill TJ, Tschetter WW, Prusky GT. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci. 2005;22:677-684.
16. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004;45:4611-4616.
17. Prusky GT, Alam NM, Douglas RM. Enhancement of vision by monocular deprivation in adult mice. J Neurosci. 2006;26:11554-11561.
18. Bragonzi A. Murine models of acute and chronic lung infection with cystic fibrosis pathogens. Int J Med Microbiol. 2010;300: 584-593.
19. Srivastava B, Błażejewska P, Heßmann M, et al. host genetic background strongly influences the response to influenza A virus infections. PLoS ONE. 2009;4:e4857.
20. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28:2735-2744.
21. Reitsamer HA, Kiel JW, Harrison JM, Ransom NL, McKinnon SJ. Tonopen measurement of intraocular pressure in mice. Exp Eye Res. 2004;78:799-804.
22. Douglas RM, Neve A, Quittenbaum JP, Alam NM, Prusky GT. Perception of visual motion coherence by rats and mice. Vision Res. 2006;46:2842-2847.
23. Baggaley AR. Intermediate Correlational Methods. New York: John Wiley & Sons; 1964.
24. Bartlett RF. Linear modelling of Pearson's product moment correlation coefficient: an application of Fisher's z-transformation. J Roy Stat Soc D-Sta. 1993;42:45-53.
25. Zhang X, Zhang M, Avila MY, Ge J, Laties AM. Time course of age-dependent changes in intraocular pressure and retinal ganglion cell death in DBA/2J mouse. Yan Ke Xue Bao. 2006;22:184-189, 194.
26. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
27. Saleh M, Nagaraju M, Porciatti V. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2007;48:4564-4572.
28. Nagaraju M, Saleh M, Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci. 2007;48:4573-4579.
29. Scholz M, Buder T, Seeber S, Adamek E, Becker CM, Lutjen-Drecoll E. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci. 2008;49:613-621.
30. Cone FE, Gelman SE, Son JL, Pease ME, Quigley HA. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp Eye Res. 2010;91:415-424.
31. Zhou X, Li F, Kong L, Chodosh J, Cao W. Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice. Mol Vis. 2009;15:438-450.
32. Wong AA, Brown RE. Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice. Neurobiol Aging. 2007;28:1577-1593.
33. Brown RE, Wong AA. The influence of visual ability on learning and memory performance in 13 strains of mice. Learn Memory. 2007;14:134-144.
34. Wilensky JT, Hawkins A. Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. Trans Am Ophthalmol Soc. 2001;99:213-217, discussion 217-218.
35. Zulauf M, Flammer J. Correlation of spatial contrast sensitivity and visual fields in glaucoma. Graefes Arch Clin Exp Ophthalmol. 1993;231:146-150.
36. McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol. 2000;84:244-250.
37. Elliott DB, Situ P. Visual acuity versus letter contrast sensitivity in early cataract. Vision Res. 1998;38:2047-2052.
38. Bayer AU, Neuhardt T, May AC, et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1258-1265.
39. Harazny J, Scholz M, Buder T, Lausen B, Kremers J. Electrophysiological deficits in the retina of the DBA/2J mouse. Doc Ophthalmol. 2009;119:181-197.
40. Kolesnikov AV, Fan J, Crouch RK, Kefalov VJ. Age-related deterioration of rod vision in mice. J Neurosci. 2010;30:11222-11231.
41. Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 2004;107:352-358.